China Automotive News: 200 LANDKING Trucks Head to Chile as WEICHAI Expands Across South America

China Automotive News: 200 LANDKING Trucks Head to Chile as WEICHAI Expands Across South America

QINGDAO, China, June 9, 2025 /PRNewswire/ -- A total of 200 LANDKING light-duty and mini trucks have been shipped to Chile, marking another significant milestone for LANDKING's expansion in the South American market. Since 2023, WEICHAI New Energy...

World First AI Marketer, Head, Triggers Huge Demand & Deep Job Security Concerns

World First AI Marketer, Head, Triggers Huge Demand & Deep Job Security Concerns

Revolutionary AI fills early access spots in hours, simultaneously igniting intense conversations and anxiety among professionals about the future of marketing roles and human creativity. SAN FRANCISCO, May 21, 2025 /PRNewswire/ -- The marketing...

Head, World's First AI Marketer, Sparks Frenzy; Spots Filled Instantly

Head, World's First AI Marketer, Sparks Frenzy; Spots Filled Instantly

Groundbreaking AI, conceptualized as a new species of marketer and brought to life by just two teenage tech visionaries, sees initial access spots vanish almost instantly, signaling a new era in intelligent capabilities. SAN FRANCISCO, May 21, 2025...

CGTN: Head-of-state diplomacy promotes ironclad friendship between China and Cambodia

CGTN: Head-of-state diplomacy promotes ironclad friendship between China and Cambodia

CGTN published an article highlighting how Chinese President Xi Jinping's visit has promoted the ironclad friendship between China and Cambodia, the fruitful results in economic and trade cooperation between the two countries, and how cultural...

Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

Head-to-Head Against Pembrolizumab: Innovent Announces First Patient Dosed in the First Pivotal Study of IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma

SAN FRANCISCO and SUZHOU, China, March 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...

menu
menu